Celltrion, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$605Kgeneral payments (2019-2025)
$5.1Mresearch payments (2019-2025)
184clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Erik Gaensler | Walnut Creek, CA | Vascular & Interventional Radiology | $167,190.00 |
| Mark Sherrid | New York, NY | Cardiovascular Disease | $70,088.24 |
| Cynthia Kleppinger | Silver Spring, MD | Family Medicine | $51,475.37 |
| Sidhartha Sinha | Stanford, CA | Gastroenterology (Internal Medicine) | $31,950.00 |
| David Brown | Houston, TX | Ophthalmology | $31,320.00 |
| Sarbjit Saini | Baltimore, MD | Allergy | $23,991.03 |
| Jonathan Plehn | Washington, DC | Cardiovascular Disease | $21,750.00 |
| James Park | New York, NY | Transplant Hepatology | $20,838.34 |
| Jean Frederick Colombel | New York, NY | Gastroenterology (Internal Medicine) | $17,115.00 |
| William Sandborn | San Diego, CA | Gastroenterology (Internal Medicine) | $16,706.25 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.